Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy von Herrero-Vicent, Carmen, Guerrero, Angel, Gavilá, Joaquin, Gozalbo, Francisco, Hernández, Abraham, Sandiego, Sergio, Algarra, Maria Asunción, Calatrava, Ana, Guillem-Porta, Vicente, Ruiz-Simón, Amparo

Volltext

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer von Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix

Volltext

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer von Garrido-Castro, Ana C, Saura, Cristina, Barroso-Sousa, Romualdo, Guo, Hao, Ciruelos, Eva, Bermejo, Begoña, Gavilá, Joaquin, Serra, Violeta, Prat, Aleix, Paré, Laia, Céliz, Pamela, Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L, Krop, Ian E, Solit, David B, Mills, Gordon B, Cantley, Lewis C, Winer, Eric P, Lin, Nancy U, Rodon, Jordi

Volltext

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentr... von Prat, Aleix, Saura, Cristina, Pascual, Tomás, Hernando, Cristina, Muñoz, Montserrat, Paré, Laia, González Farré, Blanca, Fernández, Pedro L, Galván, Patricia, Chic, Núria, González Farré, Xavier, Oliveira, Mafalda, Gil-Gil, Miguel, Arumi, Miriam, Ferrer, Neus, Montaño, Alvaro, Izarzugaza, Yann, Llombart-Cussac, Antonio, Bratos, Raquel, González Santiago, Santiago, Martínez, Eduardo, Hoyos, Sergio, Rojas, Beatriz, Virizuela, Juan Antonio, Ortega, Vanesa, López, Rafael, Céliz, Pamela, Ciruelos, Eva, Villagrasa, Patricia, Gavilá, Joaquín

Volltext

Trajectories of alcohol consumption during life and the risk of developing breast cancer von Donat-Vargas, Carolina, Guerrero-Zotano, Ángel, Casas, Ana, Baena-Cañada, José Manuel, Lope, Virginia, Antolín, Silvia, Garcia-Saénz, José Ángel, Bermejo, Begoña, Muñoz, Montserrat, Ramos, Manuel, de Juan, Ana, Jara Sánchez, Carlos, Sánchez-Rovira, Pedro, Antón, Antonio, Brunet, Joan, Gavilá, Joaquín, Salvador, Javier, Arriola Arellano, Esperanza, Bezares, Susana, Fernández de Larrea-Baz, Nerea, Pérez-Gómez, Beatriz, Martín, Miguel, Pollán, Marina

Volltext

The role of CDK4/6 inhibitors in early breast cancer von Gil-Gil, Miguel, Alba, Emilio, Gavilá, Joaquín, de la Haba-Rodríguez, Juan, Ciruelos, Eva, Tolosa, Pablo, Candini, Daniele, Llombart-Cussac, Antonio

Volltext

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication von Bellet, Meritxell, Ahmad, Faten, Villanueva, Rafael, Valdivia, Carolina, Palomino-Doza, Julián, Ruiz, Ada, Gonzàlez, Xavier, Adrover, Encarna, Azaro, Analía, Valls-Margarit, Maria, Parra, Josep Lluís, Aguilar, Juan, Vidal, Maria, Martín, Anastasi, Gavilá, Joaquín, Escrivá-de-Romaní, Santiago, Perelló, Antonia, Hernando, Cristina, Lahuerta, Ainhara, Zamora, Pilar, Reyes, Victoria, Alcalde, María, Masanas, Helena, Céliz, Pamela, Ruíz, Isabel, Gil, Miguel, Seguí, Miguel Àngel, de la Peña, Lorena

Volltext

Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer von Lorman-Carbó, Natàlia, Martínez-Sáez, Olga, Fernandez-Martinez, Aranzazu, Galván, Patricia, Chic, Nuria, Garcia-Fructuoso, Isabel, Rodríguez, Adela, Gómez-Bravo, Raquel, Schettini, Francesco, Blasco, Paula, Castillo, Oleguer, González-Farré, Blanca, Adamo, Barbara, Vidal, Maria, Muñoz, Montserrat, Perou, Charles M., Malumbres, Marcos, Gavilá, Joaquín, Pascual, Tomás, Prat, Aleix, Brasó-Maristany, Fara

Volltext

Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition von Luque, Alvaro Kohn, Schmiester, Leonard, Brasó-Maristany, Fara, González-Farré, Blanca, Pascual, Tomás, Gavilá, Joaquín, Takpli, Xavier, Geisler, Jürgen, Kristensen, Vessela N, Frigessi, Arnoldo, Prat, Aleix

Volltext

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opt... von Gavilá, Joaquín, Oliveira, Mafalda, Pascual, Tomás, Perez-Garcia, Jose, Gonzàlez, Xavier, Canes, Jordi, Paré, Laia, Calvo, Isabel, Ciruelos, Eva, Muñoz, Montserrat, Virizuela, Juan A, Ruiz, Isabel, Andrés, Raquel, Perelló, Antonia, Martínez, Jerónimo, Morales, Serafín, Marín-Aguilera, Mercedes, Martínez, Débora, Quero, Juan C, Llombart-Cussac, Antonio, Prat, Aleix

Volltext

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer von Di Cosimo, Serena, Pérez-García, José Manuel, Bellet, Meritxell, Dalenc, Florence, Gil Gil, Miguel J., Ruiz-Borrego, Manuel, Gavilá, Joaquín, Aguirre, Elena, Schmid, Peter, Marmé, Frederik, Gligorov, Joseph, Schneeweiss, Andreas, Albanell, Joan, Zamora, Pilar, Wheatley, Duncan, Martínez de Dueñas, Eduardo, Amillano, Kepa, Shimizu, Eileen, Sampayo-Cordero, Miguel, Cortés, Javier, Llombart-Cussac, Antonio

Volltext

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? von Cejalvo, Juan Miguel, Falato, Claudette, Villanueva, Lorea, Tolosa, Pablo, González, Xavier, Pascal, Mariona, Canes, Jordi, Gavilá, Joaquín, Manso, Luis, Pascual, Tomás, Prat, Aleix, Salvador, Fernando

Volltext

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial von Guerini-Rocco, Elena, Gray, Kathryn P, Fumagalli, Caterina, Reforgiato, Marta Rita, Leone, Isabella, Rafaniello Raviele, Paola, Munzone, Elisabetta, Kammler, Roswitha, Neven, Patrick, Hitre, Erika, Jerusalem, Guy, Simoncini, Edda, Gombos, Andrea, Deleu, Ines, Karlsson, Per, Aebi, Stefan, Chirgwin, Jacquie, Di Lauro, Vincenzo, Thompson, Alastair, Graas, Marie-Pascale, Barber, Matthew, Fontaine, Christel, Loibl, Sibylle, Gavilá, Joaquín, Kuroi, Katsumasa, Müller, Bettina, O'Reilly, Seamus, Di Leo, Angelo, Goldhirsch, Aron, Viale, Giuseppe, Barberis, Massimo, Regan, Meredith M, Colleoni, Marco

Volltext

Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management von Ciruelos, Eva, García-Sáenz, Jose Ángel, Gavilá, Joaquín, Martín, Miguel, Rodríguez, César A., Rodríguez-Lescure, Álvaro

Volltext

Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial von Villacampa, Guillermo, Falato, Claudette, Paré, Laia, Hernando, Cristina, Arumí, Miriam, Saura, Cristina, Gómez, Guadalupe, Muñoz, Montserrat, Gil-Gil, Miguel, Izarzugaza, Yann, Ferrer, Neus, Najera-Zuloaga, Josu, Montaño, Alvaro, Ciruelos, Eva, González-Santiago, Santiago, Villagrasa, Patricia, Gavilá, Joaquín, Prat, Aleix, Pascual, Tomás

Volltext

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, pha... von André, Fabrice, Hee Park, Yeon, Kim, Sung-Bae, Takano, Toshimi, Im, Seock-Ah, Borges, Giuliano, Lima, Joao Paulo, Aksoy, Sercan, Gavila Gregori, Joaquin, De Laurentiis, Michelino, Bianchini, Giampaolo, Roylance, Rebecca, Miyoshi, Yasuo, Armstrong, Anne, Sinha, Rajni, Ruiz Borrego, Manuel, Lim, Elgene, Ettl, Johannes, Yerushalmi, Rinat, Zagouri, Flora, Duhoux, Francois P, Fehm, Tanja, Gambhire, Dhiraj, Cathcart, Jillian, Wu, Cai, Chu, Changan, Egorov, Anton, Krop, Ian

Volltext

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with... von Olivera-Salguero, Rubén, Seguí, Elia, Cejalvo, Juan Miguel, Oliveira, Mafalda, Tolosa, Pablo, Vidal, Maria, Malumbres, Marcos, Gavilá, Joaquín, Saura, Cristina, Pernas, Sonia, López, Rafael, Margelí, Mireia, Balmaña, Judith, Muñoz, Montserrat, Blancas, Isabel, Boni, Valentina, Ciruelos, Eva, Galve, Elena, Perelló, Antonia, Sánchez-Bayona, Rodrigo, de la Cruz, Susana, de la Hoya, Miguel, Galván, Patricia, Sanfeliu, Esther, Gonzalez-Farre, Blanca, Sirenko, Valeria, Blanch-Torras, Aura, Canes, Jordi, Masanas, Helena, Olmos, Rosa, Forns, Margarita, Prat, Aleix, Casas, Ana, Pascual, Tomás

Volltext

Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIF... von Di Cosimo, Serena, Pérez-García, José Manuel, Bellet, Meritxell, Dalenc, Florence, Gil Gil, Miguel J, Ruiz Borrego, Manuel, Gavilá, Joaquín, Sampayo-Cordero, Miguel, Aguirre, Elena, Schmid, Peter, Marmé, Frederik, Gligorov, Joseph, Schneeweiss, Andreas, Albanell, Joan, Zamora, Pilar, Wheatley, Duncan, Martínez-De Dueñas, Eduardo, Carañana, Vicente, Amillano, Kepa, Mina, Leonardo, Malfettone, Andrea, Cortés, Javier, Llombart-Cussac, Antonio

Volltext

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS) von Blanch, Salvador, Gil-Gil, Juan Miguel, Arumí, Miriam, Aguirre, Elena, Seguí, Miguel Ángel, Atienza, Manuel, Díaz-Cerezo, Silvia, Molero, Alberto, Cervera, José Manuel, Gavilá, Joaquín

Volltext

Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy von Pascual, Tomás, Fernandez-Martinez, Aranzazu, Agrawal, Yash, Pfefferle, Adam D., Chic, Nuria, Brasó-Maristany, Fara, Gonzàlez-Farré, Blanca, Paré, Laia, Villacampa, Guillermo, Saura, Cristina, Hernando, Cristina, Muñoz, Montserrat, Galván, Patricia, Gonzàlez-Farré, Xavier, Oliveira, Mafalda, Gil-Gil, Miguel, Ciruelos, Eva, Villagrasa, Patricia, Gavilá, Joaquín, Prat, Aleix, Perou, Charles M.

Volltext